M

MeiraGTx Holdings plc
D

MGTX

8.37000
USD
0.06
(0.72%)
مغلق
حجم التداول
21,613
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
672,658,055
أصول ذات صلة
LI
LI
-0.005
(-0.02%)
29.585 USD
N
NIO
0.10000
(2.07%)
4.92500 USD
RIVN
RIVN
0.180
(1.30%)
14.000 USD
TSLA
TSLA
10.99
(3.60%)
316.11 USD
W
WKHS
-0.15500
(-7.40%)
1.94000 USD
XPEV
XPEV
-0.190
(-0.99%)
18.960 USD
المزيد
الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.